BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Aradigm Corporation (OB: ARDM)
0.0981 USD  -0.0019 (-1.90%)
Streaming Delayed Price  /  Updated: 10:47 AM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 17,630
Open 0.0900
Bid (Size) 0.0800 (10000)
Ask (Size) 0.1900 (5000)
Prev. Close 0.1000
Today's Range 0.0900 - 0.0990
52wk Range 0.0910 - 0.1800
Shares Outstanding 251,693,888
Dividend Yield N/A
Top News
More News
Aradigm Announces First Quarter 2013 Financial Results
May 14, 2013
from Business Wire News Releases
Aradigm Announces Fourth Quarter 2012 and Full Year Financial Results
March 26, 2013
from Business Wire News Releases

More News
Read More
Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2013 on February 12
February 06, 2013
from Business Wire News Releases
Aradigm to Present at Biotech Showcase 2013 on January 9
January 03, 2013
from Business Wire News Releases
Aradigm Announces Private Placement for $6 Million
December 12, 2012
from Business Wire News Releases
UK Scientists Report on Efficacy of Aradigm’s Lipoquin™ Against Pneumonic Plague
November 19, 2012
from Business Wire News Releases
Aradigm Announces Third Quarter 2012 Financial Results
November 08, 2012
from Business Wire News Releases
Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm’s Inhaled Liposomal Ciprofloxacin
October 16, 2012
from Business Wire News Releases
UK Scientists Report Successful Testing of Aradigm’s Inhaled Liposomal Ciprofloxacin in Q Fever
September 20, 2012
from Business Wire News Releases
New U.S. Composition of Matter Patent for Aradigm’s Pulmaquin™ and Lipoquin™ Provides Protection Until 2031
September 18, 2012
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK